Belgium: Chemicals Cefic Reacts to ECHA’s Progress Report on Dossier and Substance Evaluation
Cefic is interacting with ECHA and member companies to make ‘Reach’ work. It is also assessing how it can further help its members to carry out the process with ease.
Brussels/Belgium – The EU chemical industry is committed to making Reach (Registration, Evaluation, Authorisation and Restriction of Chemicals) work. It acknowledges that data gaps need to be tackled more swiftly and efficiently. Cefic is also liaising with ECHA and member companies to facilitate this work. Cefic is now assessing how it can further help its members with this process.
ECHA’s 2018 progress report
Under Article 54 of Reach, ECHA reported on the progress made in 2018 in dossier and substance evaluation.
ECHA assessed 484 registrations either under compliance check (CCH) or under testing proposal examination (TPE), corresponding to 420 substances. ECHA issued 379 draft decisions: 211 on compliance check and 168 on testing proposal examination. The selection of registrations for compliance check was mainly based on a potential hazard- or exposure-based concern.
At the end of the year, there were still 45 dossiers undergoing compliance check and 65 dossiers undergoing testing proposal examination.
ECHA adopted 274 final decisions in which 888 information requests were made. Out of these 274 decisions, 144 were compliance check decisions and 130 originating from testing proposal examinations.
Out of the 274 final decisions, 216 were adopted without Member State Committee (MSC) involvement (no proposal for amendments received from Member States). 58 decisions were adopted with MSC involvement: 34 in written procedure and 24 in an MSC meeting.
At the end of 2018, there were another 174 compliance check and 109 testing proposal examination draft decisions from previous year in decision making. ECHA closed 52 compliance check cases and 44 testing proposal examination cases after a draft decision has been sent, as scientifically-relevant data or important administrative changes led to termination of the ongoing decision-making procedure.
Two draft decisions were referred to the Commission for decision making, both related to the design of the extended one-generation reproductive toxicity study design.